Sutro Biopharma Inc (NASDAQ:STRO)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - STRO
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - STRO
- Market Cap$1.148bn
- SymbolNASDAQ:STRO
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS8693671021
Company Profile
Sutro Biopharma Inc is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Latest STRO news
Currently there for this company. Visit our news hub for other news .